SARS-CoV-2–infected individuals may suffer a multi–organ system disorder known as “long
COVID” or post-acute sequelae of SARS-CoV-2 infection (PASC). There are no standard …

Severe acute respiratory syndrome-associated coronavirus-2 (SARS-CoV-2) is the causal
agent of coronavirus disease-2019 (COVID-19), a systemic illness characterized by variably …

Since the very beginning of the coronavirus disease 2019 (COVID-19) pandemic in early
2020, it was evident that patients with cardiovascular disease (CVD) were at an increased …

Abstract Coronavirus disease 2019 (COVID-19) is associated with an increased risk of
thrombotic events. Ischemic stroke in COVID-19 patients entails high severity and mortality …

The coagulation, fibrinolytic, anticoagulation, and complement systems are in delicate
balance with the vessel wall endothelium ensuring appropriate hemostasis. Coagulopathy …

The COVID-19 pandemic, caused by SARS-CoV-2, had its first cases identified in late 2019
and was considered a clinical pandemic in March 2020. In March 2022, more than 500 …

Abstract Coronavirus disease 2019 (COVID-19) is a consequence of infection of the upper
and lower respiratory tract with severe acute respiratory syndrome coronavirus 2 but often …

Geroscience, an emerging discipline at the intersection of aging and disease, seeks to
understand the relationship between the aging process and pathogenesis of age-related …

Coronavirus disease 2019 (COVID-19) is known to commonly induce a thrombotic diathesis,
particularly in severely affected individuals. So far, this COVID-19-associated coagulopathy …

The hallmark of heart failure (HF) is structural myocardial remodeling including
cardiomyocyte hypertrophy, fibrosis, cardiomyocyte cell death, and a low-grade aseptic …